16 December 2021 — Inventia Life Science, a world leader in advanced 3D cell cultures for research and clinical purposes, has today announced the close of a AU$35m Series B funding round, led by ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果当前正在显示可能无法访问的结果。
隐藏无法访问的结果